Premium
Eosinophilic annular erythema treated with dupilumab
Author(s) -
Gordon Samantha C.,
Robinson Sarah N.,
Abudu Minawaer,
Her Michelle,
Deverapalli Sandyha,
Levin Adrianne,
Schmidt Birgitta A. R.,
Gellis Stephen E.,
Rosmarin David
Publication year - 2018
Publication title -
pediatric dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.542
H-Index - 73
eISSN - 1525-1470
pISSN - 0736-8046
DOI - 10.1111/pde.13533
Subject(s) - dupilumab , medicine , erythema , eosinophilia , eosinophilic , dermatology , eosinophil , pathology , immunology , atopic dermatitis , asthma
Eosinophilic annular erythema is a rare, benign, recurrent condition characterized by annular skin lesions, tissue eosinophilia, and resistance to a variety of treatments. There are fewer than 30 cases reported in the English literature, 7 of which are in children. We present a case of recurrent eosinophilic annular erythema in an adolescent that was successfully treated with dupilumab, an interleukin‐4 receptor alpha antagonist.